Cargando…

N-terminal region is responsible for mHv1 channel activity in MDSCs

Voltage-gated proton channels (Hv1) are important regulators of the immunosuppressive function of myeloid-derived suppressor cells (MDSCs) in mice and have been proposed as a potential therapeutic target to alleviate dysregulated immunosuppression in tumors. However, till date, there is a lack of ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Peña-Pichicoi, Antonio, Fernández, Miguel, Navarro-Quezada, Nieves, Alvear-Arias, Juan J., Carrillo, Christian A., Carmona, Emerson M., Garate, Jose, Lopez-Rodriguez, Angelica M., Neely, Alan, Hernández-Ochoa, Erick O., González, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616795/
https://www.ncbi.nlm.nih.gov/pubmed/37915407
http://dx.doi.org/10.3389/fphar.2023.1265130
_version_ 1785129472884736000
author Peña-Pichicoi, Antonio
Fernández, Miguel
Navarro-Quezada, Nieves
Alvear-Arias, Juan J.
Carrillo, Christian A.
Carmona, Emerson M.
Garate, Jose
Lopez-Rodriguez, Angelica M.
Neely, Alan
Hernández-Ochoa, Erick O.
González, Carlos
author_facet Peña-Pichicoi, Antonio
Fernández, Miguel
Navarro-Quezada, Nieves
Alvear-Arias, Juan J.
Carrillo, Christian A.
Carmona, Emerson M.
Garate, Jose
Lopez-Rodriguez, Angelica M.
Neely, Alan
Hernández-Ochoa, Erick O.
González, Carlos
author_sort Peña-Pichicoi, Antonio
collection PubMed
description Voltage-gated proton channels (Hv1) are important regulators of the immunosuppressive function of myeloid-derived suppressor cells (MDSCs) in mice and have been proposed as a potential therapeutic target to alleviate dysregulated immunosuppression in tumors. However, till date, there is a lack of evidence regarding the functioning of the Hvcn1 and reports on mHv1 isoform diversity in mice and MDSCs. A computational prediction has suggested that the Hvcn1 gene may express up to six transcript variants, three of which are translated into distinct N-terminal isoforms of mHv1: mHv1.1 (269 aa), mHv1.2 (269 + 42 aa), and mHv1.3 (269 + 4 aa). To validate this prediction, we used RT-PCR on total RNA extracted from MDSCs, and the presence of all six predicted mRNA variances was confirmed. Subsequently, the open-reading frames (ORFs) encoding for mHv1 isoforms were cloned and expressed in Xenopus laevis oocytes for proton current recording using a macro-patch voltage clamp. Our findings reveal that all three isoforms are mammalian mHv1 channels, with distinct differences in their activation properties. Specifically, the longest isoform, mHv1.2, displays a right-shifted conductance–voltage (GV) curve and slower opening kinetics, compared to the mid-length isoform, mHv1.3, and the shortest canonical isoform, mHv1.1. While mHv1.3 exhibits a V(0.5) similar to that of mHv1.1, mHv1.3 demonstrates significantly slower activation kinetics than mHv1.1. These results suggest that isoform gating efficiency is inversely related to the length of the N-terminal end. To further explore this, we created the truncated mHv1.2 ΔN20 construct by removing the first 20 amino acids from the N-terminus of mHv1.2. This construct displayed intermediate activation properties, with a V(0.5) value lying intermediate of mHv1.1 and mHv1.2, and activation kinetics that were faster than that of mHv1.2 but slower than that of mHv1.1. Overall, these findings indicate that alternative splicing of the N-terminal exon in mRNA transcripts encoding mHv1 isoforms is a regulatory mechanism for mHv1 function within MDSCs. While MDSCs have the capability to translate multiple Hv1 isoforms with varying gating properties, the Hvcn1 gene promotes the dominant expression of mHv1.1, which exhibits the most efficient gating among all mHv1 isoforms.
format Online
Article
Text
id pubmed-10616795
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106167952023-11-01 N-terminal region is responsible for mHv1 channel activity in MDSCs Peña-Pichicoi, Antonio Fernández, Miguel Navarro-Quezada, Nieves Alvear-Arias, Juan J. Carrillo, Christian A. Carmona, Emerson M. Garate, Jose Lopez-Rodriguez, Angelica M. Neely, Alan Hernández-Ochoa, Erick O. González, Carlos Front Pharmacol Pharmacology Voltage-gated proton channels (Hv1) are important regulators of the immunosuppressive function of myeloid-derived suppressor cells (MDSCs) in mice and have been proposed as a potential therapeutic target to alleviate dysregulated immunosuppression in tumors. However, till date, there is a lack of evidence regarding the functioning of the Hvcn1 and reports on mHv1 isoform diversity in mice and MDSCs. A computational prediction has suggested that the Hvcn1 gene may express up to six transcript variants, three of which are translated into distinct N-terminal isoforms of mHv1: mHv1.1 (269 aa), mHv1.2 (269 + 42 aa), and mHv1.3 (269 + 4 aa). To validate this prediction, we used RT-PCR on total RNA extracted from MDSCs, and the presence of all six predicted mRNA variances was confirmed. Subsequently, the open-reading frames (ORFs) encoding for mHv1 isoforms were cloned and expressed in Xenopus laevis oocytes for proton current recording using a macro-patch voltage clamp. Our findings reveal that all three isoforms are mammalian mHv1 channels, with distinct differences in their activation properties. Specifically, the longest isoform, mHv1.2, displays a right-shifted conductance–voltage (GV) curve and slower opening kinetics, compared to the mid-length isoform, mHv1.3, and the shortest canonical isoform, mHv1.1. While mHv1.3 exhibits a V(0.5) similar to that of mHv1.1, mHv1.3 demonstrates significantly slower activation kinetics than mHv1.1. These results suggest that isoform gating efficiency is inversely related to the length of the N-terminal end. To further explore this, we created the truncated mHv1.2 ΔN20 construct by removing the first 20 amino acids from the N-terminus of mHv1.2. This construct displayed intermediate activation properties, with a V(0.5) value lying intermediate of mHv1.1 and mHv1.2, and activation kinetics that were faster than that of mHv1.2 but slower than that of mHv1.1. Overall, these findings indicate that alternative splicing of the N-terminal exon in mRNA transcripts encoding mHv1 isoforms is a regulatory mechanism for mHv1 function within MDSCs. While MDSCs have the capability to translate multiple Hv1 isoforms with varying gating properties, the Hvcn1 gene promotes the dominant expression of mHv1.1, which exhibits the most efficient gating among all mHv1 isoforms. Frontiers Media S.A. 2023-10-17 /pmc/articles/PMC10616795/ /pubmed/37915407 http://dx.doi.org/10.3389/fphar.2023.1265130 Text en Copyright © 2023 Peña-Pichicoi, Fernández, Navarro-Quezada, Alvear-Arias, Carrillo, Carmona, Garate, Lopez-Rodriguez, Neely, Hernández-Ochoa and González. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Peña-Pichicoi, Antonio
Fernández, Miguel
Navarro-Quezada, Nieves
Alvear-Arias, Juan J.
Carrillo, Christian A.
Carmona, Emerson M.
Garate, Jose
Lopez-Rodriguez, Angelica M.
Neely, Alan
Hernández-Ochoa, Erick O.
González, Carlos
N-terminal region is responsible for mHv1 channel activity in MDSCs
title N-terminal region is responsible for mHv1 channel activity in MDSCs
title_full N-terminal region is responsible for mHv1 channel activity in MDSCs
title_fullStr N-terminal region is responsible for mHv1 channel activity in MDSCs
title_full_unstemmed N-terminal region is responsible for mHv1 channel activity in MDSCs
title_short N-terminal region is responsible for mHv1 channel activity in MDSCs
title_sort n-terminal region is responsible for mhv1 channel activity in mdscs
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616795/
https://www.ncbi.nlm.nih.gov/pubmed/37915407
http://dx.doi.org/10.3389/fphar.2023.1265130
work_keys_str_mv AT penapichicoiantonio nterminalregionisresponsibleformhv1channelactivityinmdscs
AT fernandezmiguel nterminalregionisresponsibleformhv1channelactivityinmdscs
AT navarroquezadanieves nterminalregionisresponsibleformhv1channelactivityinmdscs
AT alvearariasjuanj nterminalregionisresponsibleformhv1channelactivityinmdscs
AT carrillochristiana nterminalregionisresponsibleformhv1channelactivityinmdscs
AT carmonaemersonm nterminalregionisresponsibleformhv1channelactivityinmdscs
AT garatejose nterminalregionisresponsibleformhv1channelactivityinmdscs
AT lopezrodriguezangelicam nterminalregionisresponsibleformhv1channelactivityinmdscs
AT neelyalan nterminalregionisresponsibleformhv1channelactivityinmdscs
AT hernandezochoaericko nterminalregionisresponsibleformhv1channelactivityinmdscs
AT gonzalezcarlos nterminalregionisresponsibleformhv1channelactivityinmdscs